

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Mepolizumab is a specialized medication designed to help people with severe asthma and other inflammatory conditions breathe easier. This injectable treatment works by targeting specific immune system cells that cause inflammation in your airways, offering hope for those who haven't found relief with traditional asthma medications.
If you're considering this treatment or your doctor has recommended it, you likely have questions about how it works and what to expect. Let's walk through everything you need to know about this medication in clear, straightforward terms.
Mepolizumab is a biologic medication that belongs to a class of drugs called monoclonal antibodies. Think of it as a highly targeted treatment that zeroes in on specific troublemakers in your immune system.
This medication specifically blocks a protein called interleukin-5 (IL-5), which controls the production and activity of eosinophils. Eosinophils are white blood cells that normally help fight infections, but in some people, they become overactive and cause inflammation in the lungs and other organs.
You'll receive mepolizumab as a subcutaneous injection, which means it goes into the fatty tissue just under your skin. The brand name for this medication is Nucala, and it's manufactured as a solution that healthcare providers inject every four weeks.
Mepolizumab treats several serious conditions where eosinophils cause harmful inflammation throughout your body. Your doctor might recommend this medication if you have severe asthma that doesn't respond well to standard treatments.
The primary conditions mepolizumab helps with include severe eosinophilic asthma, where high levels of eosinophils make your asthma difficult to control. It's also used for eosinophilic granulomatosis with polyangiitis (EGPA), a rare condition that causes inflammation in blood vessels and organs.
Additionally, mepolizumab treats hypereosinophilic syndrome (HES), a group of disorders where your body produces too many eosinophils. This medication can also help with chronic rhinosinusitis with nasal polyps when eosinophils contribute to the inflammation.
Your doctor will only consider mepolizumab if you have high eosinophil counts in your blood and your current treatments aren't providing adequate control of your symptoms.
Mepolizumab works by acting like a targeted blocker in your immune system. It attaches to and neutralizes IL-5, a chemical messenger that tells your body to make more eosinophils.
When IL-5 is blocked, your body produces fewer eosinophils, and the existing ones become less active. This reduction helps calm the inflammation in your airways and other affected tissues, making it easier for you to breathe and reducing other symptoms.
This medication is considered a strong, specialized treatment that's reserved for people with severe conditions. Unlike quick-relief inhalers that work within minutes, mepolizumab builds up in your system over time and provides long-term control.
You'll typically notice improvements in your symptoms after several weeks or months of treatment, as your eosinophil levels gradually decrease and inflammation subsides.
Mepolizumab comes as a pre-filled syringe or autoinjector that you'll receive as an injection every four weeks. Your healthcare provider will give you the first few injections to ensure you're comfortable with the process and to monitor for any reactions.
The injection goes into the fatty tissue under your skin, typically in your thigh, upper arm, or abdomen. You can rotate injection sites to prevent irritation, and your healthcare team will teach you the proper technique if you'll be giving yourself injections at home.
You don't need to take this medication with food or water since it's an injection, but you should try to schedule your injections around the same time each month. Keep the medication refrigerated until you're ready to use it, but let it come to room temperature before injecting.
It's important to continue taking your other asthma medications as prescribed, even after starting mepolizumab. This injection works alongside your existing treatments, not as a replacement for them.
The duration of mepolizumab treatment varies depending on your specific condition and how well you respond to the medication. Many people continue this treatment for months or even years to maintain control of their symptoms.
Your doctor will regularly monitor your eosinophil levels and symptoms to determine if the medication is working effectively. If you're seeing good results, you'll likely continue treatment long-term, as stopping mepolizumab often leads to a return of symptoms.
Some people may be able to reduce the frequency of injections or eventually stop treatment if their condition improves significantly. However, this decision should always be made in close consultation with your healthcare provider.
Regular follow-up appointments are essential to assess your progress and adjust your treatment plan as needed. Your doctor might recommend stopping mepolizumab if you're not seeing benefits after several months or if you develop concerning side effects.
Like all medications, mepolizumab can cause side effects, though many people tolerate it well. The most common side effects are generally mild and manageable with proper care.
Here are the side effects you might experience, starting with the most common ones:
These common side effects usually improve on their own and don't require stopping the medication. However, you should always discuss any persistent or bothersome symptoms with your healthcare provider.
Some people experience more serious but less common side effects that require immediate medical attention. These include severe allergic reactions with symptoms like difficulty breathing, swelling of your face or throat, or widespread rash.
Rare but serious side effects can include severe infections, as mepolizumab affects your immune system. You might also experience shingles (herpes zoster) reactivation or other opportunistic infections in very rare cases.
If you notice any unusual symptoms, persistent fever, or signs of infection, contact your healthcare provider promptly. They can help determine if these symptoms are related to your medication and adjust your treatment if necessary.
Mepolizumab isn't suitable for everyone, and certain health conditions or circumstances make this medication inappropriate or potentially dangerous. Your doctor will carefully evaluate your medical history before prescribing it.
You should not take mepolizumab if you've had a severe allergic reaction to this medication or any of its ingredients in the past. People with active, untreated infections should also avoid this medication until their infection clears.
Here are situations where mepolizumab may not be recommended:
If you're breastfeeding, pregnant, or planning to become pregnant, discuss this thoroughly with your doctor. While mepolizumab hasn't been extensively studied in pregnant women, your healthcare provider can help weigh the potential benefits against any risks.
Children under 6 years old typically don't receive mepolizumab, as safety and effectiveness haven't been established for very young children. Your doctor will consider your age, overall health, and specific condition when determining if this medication is right for you.
Mepolizumab is available under the brand name Nucala in most countries, including the United States, Canada, and Europe. This is the only brand name currently available for this medication.
Nucala comes in different formulations, including pre-filled syringes and autoinjectors, depending on your specific needs and preferences. Your healthcare provider will help you choose the most appropriate option based on your comfort level with self-injection and your prescribed dose.
There are no generic versions of mepolizumab available yet, as this medication is still protected by patents. This means Nucala is currently the only way to access this specific treatment.
Several other biologic medications work similarly to mepolizumab for treating severe asthma and eosinophilic conditions. Your doctor might consider these alternatives if mepolizumab isn't suitable for you or doesn't provide adequate symptom control.
Other anti-IL-5 medications include benralizumab (Fasenra), which works by targeting the IL-5 receptor, and reslizumab (Cinqair), which blocks IL-5 like mepolizumab but is given intravenously. These medications have similar mechanisms but different dosing schedules and administration methods.
For severe asthma, your doctor might also consider omalizumab (Xolair), which targets IgE antibodies, or dupilumab (Dupixent), which blocks different inflammatory pathways. The choice depends on your specific type of asthma and your individual response patterns.
Traditional treatments like high-dose inhaled corticosteroids, long-acting bronchodilators, and oral corticosteroids remain important parts of treatment plans. Your doctor will work with you to find the combination of treatments that provides the best symptom control with the fewest side effects.
Mepolizumab and omalizumab are both effective biologic treatments for severe asthma, but they work through different mechanisms and are better suited for different types of patients. Neither medication is universally "better" than the other.
Mepolizumab specifically targets people with high eosinophil counts and is particularly effective for eosinophilic asthma. Omalizumab works better for people with allergic asthma who have high IgE levels and specific allergen triggers.
Your doctor will determine which medication is more appropriate based on your blood test results, asthma triggers, and symptom patterns. Some people with eosinophilic asthma respond dramatically to mepolizumab, while others with allergic asthma see better results with omalizumab.
The dosing schedules also differ, with mepolizumab given monthly and omalizumab given every 2-4 weeks depending on your dose. Your lifestyle preferences and comfort with injection frequency might influence which option works better for you.
Is Mepolizumab Safe for People with Diabetes?
Mepolizumab is generally safe for people with diabetes, as it doesn't directly affect blood sugar levels or interfere with diabetes medications. However, you should always inform your healthcare provider about your diabetes when starting any new medication.
Some people with diabetes may have a slightly higher risk of infections, which could be a consideration since mepolizumab affects your immune system. Your doctor will monitor you closely and may recommend additional precautions to prevent infections.
What Should I Do If I Accidentally Use Too Much Mepolizumab?
If you accidentally inject too much mepolizumab, contact your healthcare provider or seek medical attention immediately. While overdoses are rare with this medication, it's important to get professional guidance.
Don't try to "fix" the situation by skipping future doses or changing your injection schedule on your own. Your healthcare provider will assess your situation and determine the best course of action, which might include closer monitoring or adjusting your next scheduled dose.
What Should I Do If I Miss a Dose of Mepolizumab?
If you miss your scheduled mepolizumab injection, contact your healthcare provider as soon as possible to reschedule. Generally, you should take the missed dose as soon as you remember, then continue with your regular monthly schedule.
Don't double up on doses or try to make up for missed injections by taking extra medication. Your healthcare provider will help you get back on track with your treatment schedule while ensuring your safety.
When Can I Stop Taking Mepolizumab?
You should only stop taking mepolizumab under the guidance of your healthcare provider. Many people need to continue this medication long-term to maintain control of their symptoms, and stopping abruptly can lead to a return of inflammation and symptoms.
Your doctor will regularly assess your progress and may consider reducing the frequency of injections or stopping treatment if your condition has improved significantly and remained stable for an extended period. This decision depends on your individual response and the underlying condition being treated.
Can I Travel While Taking Mepolizumab?
Yes, you can travel while taking mepolizumab, but you'll need to plan ahead to maintain your injection schedule. If you're traveling during a scheduled injection time, work with your healthcare provider to arrange treatment at your destination or adjust your schedule slightly.
When traveling with mepolizumab, keep the medication refrigerated and carry a letter from your doctor explaining your medical need for the injection. Airport security and customs officials may need to verify that you're carrying legitimate medication for personal medical use.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.